A COVID-19 vaccine developed by Chinas Sinovac was found to have an efficacy rate of slightly above 50% in Brazilian clinical trials.
Moento wa COVID-19 o o tlhamilweng ke Sinovac ya wa China o lemogilwe o na le kgono e e kwa godimonyana ga 50% kwa ditekong tsa setliniki tsa kwa Brazil.